MRI sales drive Intermagnetics revenues

AuntMinnie.com staff writers
Mar 20, 2002

MRI components provider Intermagnetics General reported fiscal third-quarter net sales of $37.2 million, up 8% compared with the $34.3 million reported in the same period last year. For the period (end-February 24), the Latham, NY-based vendor had net income of $3.1 million, compared with net income of $2.9 million a year ago.

In quarterly highlights, MRI magnet systems sales were $27.5 million, up 41% compared with the $19.4 million booked in the 2001 fiscal third quarter. Overall MRI segment sales grew 30% to $31 million, according to the company.

By AuntMinnie.com staff writers
March 21, 2002

Related Reading

Intermagnetics promotes Blecher, October 16, 2001

Intermagnetics notches record revenue, earnings, September 21, 2001

Copyright © 2002 AuntMinnie.com

Latest in MRI
Contrast Injector
Ferumoxytol-enhanced MRA is safe for chronic kidney disease patients
January 29, 2025
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
Sponsored
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
January 1, 2025
Cannabis Marijuana
63% of heavy cannabis users show reduced working memory ability
January 28, 2025
Brain Mri
Brain MRI tracks risk of stage IV breast cancer metastases
January 24, 2025
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2002 02 28 14 45 46 706
MRI
New tissue-tracking echocardiography shows heart wall abnormalities
2002 02 28 14 45 46 706
MRI
MRA gauges spiral blood flow as predictor of renal deterioration
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
Sponsor Content
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
More in MRI
Ferumoxytol-enhanced MRA is safe for chronic kidney disease patients
By Kate Madden Yee
Ferumoxytol-enhanced MR angiography (MRA) appears to be safe for chronic kidney disease patients, researchers have reported.
January 29, 2025
Contrast Injector
Ultrafast MRI exam bests standard MRI for classifying breast cancers
By Amerigo Allegretto
An ultrafast MRI-based radiomics exam performs just as well as standard MRI and isn’t dependent on radiologist experience.
January 28, 2025
Ultrafast and standard MRI in a 30-year-old woman with triple-negative invasive ductal carcinoma. (A) Ultrafast MRI taken 16.8 seconds after contrast agent injection. (B) Standard MRI taken 58.8 seconds after contrast agent injection. Both images show an oval-shaped, irregular marginated, rim-enhancing mass in the left outer breast. For 3D tumor segmentation, the entire enhanced tumor margins were drawn from top to bottom of each tumor in axial views of U2 phase postcontrast ultrafast MRI and the initial phase postcontrast standard MRI. Among the 14 ultrafast images, U1 is the first phase in which the signal intensity of the hotspot region of interest of the tumor is 10% higher than the average signal intensity of unenhanced images. U2 is the immediate next phase of U1 and the well-established tumor enhancement time.
63% of heavy cannabis users show reduced working memory ability
By Kate Madden Yee
Functional MRI reveals that 63% of heavy lifetime cannabis users show reduced brain activity during a working memory task -- and that 68% of recent users also show this impact.
January 28, 2025
Cannabis Marijuana
Brain MRI tracks risk of stage IV breast cancer metastases
By Kate Madden Yee
Brain MRI shows promise for surveilling women at risk for asymptomatic stage IV breast cancer metastases by tracking molecular subtypes of the disease.
January 24, 2025
Brain Mri
MR spectroscopy reveals neurochemical patterns linked to COVID-19
By Kate Madden Yee
Proton MR spectroscopy (MRS) reveals "remarkable" neurochemical patterns associated with COVID-19-induced anosmia, or loss of smell.
January 23, 2025
Mri Brain
Simulated contrast-enhanced MRI helps assess prostate cancer
By Kate Madden Yee
Simulated contrast-enhanced MR images from noncontrast sequences using deep learning show promise for assessing clinically significant prostate cancer.
January 15, 2025
2025 01 14 Radiology Huang Figure5 Thumbnail
Measuring myelin volume with synthetic MRI helps predict stroke outcomes
By Kate Madden Yee
Stroke patients with large total myelin volume measured on synthetic MR imaging appear to have good functional outcomes on follow-up.
January 15, 2025
Brain Stroke
ML model using CCTA, MRI data predicts MACE in cardiac patients
By Amerigo Allegretto
A machine-learning (ML) model that includes both CCTA and stress cardiac MRI data can accurately predict major adverse cardiovascular events (MACE).
January 14, 2025
Heart Valves 3 D Base Thumbnail
Genetic testing, risk assessment tied to more breast MRI uptake
By Amerigo Allegretto
Women with high-risk pathological variants for breast cancer as identified by genetic testing and risk assessment are more likely to undergo breast MRI.
January 13, 2025
Mri Breast 400
Deep-learning model based on MRI data predicts prostate cancer risk
By Kate Madden Yee
A deep-learning model based on MRI and clinical parameters appears effective for predicting the risk of prostate cancer progression.
January 10, 2025
Prostate Cancer 3 D Rendering
Breast MRI surveillance reduces disease recurrence
By Kate Madden Yee
In women with a personal history of breast cancer, postoperative MRI surveillance appears to lower their odds of advanced second breast cancer.
January 7, 2025
Mri Breast Cancer
Women with BRCA1/2 germline mutations are often denied breast MRI
By Kate Madden Yee
Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.
January 3, 2025
Mri Breast Cancer
Page 1 of 612
Next Page